Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Predictive Oncology Inc. - Common Stock (NQ:POAI)

8.900 +0.440 (+5.20%)
Streaming Delayed Price Updated: 2:58 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Predictive Oncology Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy
From Predictive Oncology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy
From Predictive Oncology Inc.
Via GlobeNewswire
Wondering what's happening in today's pre-market session?
Discover the top movers in Monday's pre-market session and stay informed about market dynamics. 
Via Chartmill
Predictive Oncology Stock Receives Significant Investor Interest Today – Here Are Two Important Developments
Via Stocktwits
Predictive Oncology Shares Tumble 19% On Reverse Stock Split Announcement – More Details Inside
Via Stocktwits
CryptoNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Prices $344.4 Million in PIPEs to Launch Digital Asset Treasury Strategy
Via CryptoCurrencyWire
Topics Artificial Intelligence
CryptoNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Prices $344.4 Million in PIPEs to Launch Digital Asset Treasury Strategy
Via Investor Brand Network
Topics Artificial Intelligence
Let's take a look at the stocks that are in motion in today's session.
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
Nasdaq-Listed Predictive Oncology Forges $344.4M Decentralized AI Alliance with DNA Holdings and Aethir, Signaling Major Wall Street-Crypto Convergence
DNA Holdings has strategically advised and invested in a landmark $344.4 million capital deal that sees Nasdaq-listed Predictive Oncology Inc. (NASDAQ: POAI) establishing a pioneering "Strategic... 
Via MarketMinute
Topics Artificial Intelligence Economy
Top stock movements in today's session.
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
Nasdaq Jumps 150 Points; US Pending Home Sales Rise
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. Following the market opening Monday, the Dow traded up 0.19% to 46,333.68 while the NASDAQ rose... 
Via Benzinga
Topics Stocks
Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens
From Predictive Oncology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their outstanding shares is at $87.2 million. 
Via Benzinga
Predictive Oncology Announces 1-for-15 Reverse Stock Split
Common Stock Will Begin Trading on Split-Adjusted Basis on September 30, 2025 
From Predictive Oncology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients
Collaboration builds upon positive results utilizing Predictive Oncology’s AI platform to identify new indications for existing drugs 
From Predictive Oncology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
From Kahn Swick & Foti, LLC
Via GlobeNewswire
POAI Reports Earnings
Via The Motley Fool
Topics Artificial Intelligence
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapies 
From Predictive Oncology Inc.
Via GlobeNewswire
Court Denies Renovaro Motion for an Expedited Trial in July
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish
Renovaro said the Delaware Court of Chancery had approved an expedited trial schedule for the lawsuit it filed to enforce a binding merger agreement with Predictive Oncology. 
Via Stocktwits
Topics Artificial Intelligence Lawsuit
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.